Half the world’s population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends continue, says a study published in the journal Ophthalmology.
Ophthotech Corporation to Present at RBC Capital Markets Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the RBC Capital Markets Healthcare Conference on Wednesday, February 24, 2016.
Uncategorized
Seize the day and the future
At the conclusion of the Asia-Pacific Academy of Ophthalmology congress held in conjunction with the All India Ophthalmological Society conference in Hyderabad, India, which brought together more than 9,000 delegates and more than 1,000 invited speaker…
Half the world to be short-sighted by 2050
Half the world’s population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends…
Data Dump: U.S. Trials Often Fail to Report Results (CME/CE)
(MedPage Today) — “Poor performance and noticeable variation” in dissemination of clinical trial findings
Uncategorized
Senate committee proposes more efficient approval of medical devices
The U.S. Senate Committee on Health, Education, Labor and Pensions favorably reported legislation that would streamline the FDA’s evaluation process for medical devices, one of seven biomedical innovation bills currently advancing to the full Senate for consideration.The FDA Device Accountability Act of 2015 (S. 1622), sponsored by Sens. Richard Burr, R-N.C., and Al Franken, D-Minn., and co-sponsored by Mark Kirk, R-Ill., is intended to ensure the “least burdensome means” of evaluating medical devices, according to the bill’s authors.